Sanofi has agreed a deal to buy US biopharma company Provention Bio for $2.9 billion, taking control of a recently-approved type 1 diabetes ... Medicines & Healthcare products Regulatory Agency ...

Sanofi has moved a step closer to getting its new diabetes therapy Zynquista approved in Europe, with a positive opinion from the Committee for Medicinal Products for Human Use (CHMP).

Columbus City Attorney Zach Klein announced that the city has filed a lawsuit against several drug companies and pharmacy ...

Today, Google Life Sciences entered a partnership with Sanofi, a European pharmaceutical company, to develop technologies to treat diabetes. The partnership reinforces Google Life Sciences ...

Metabolex has entered into an agreement with Sanofi–Aventis for the development of ... is in a Phase II trial for the treatment of type 2 diabetes (T2D). Metabolex will receive upfront and ...

Sanofi–Aventis has signed an agreement with CureDM ... islet neogenesis — for the treatment of type 1 and type 2 diabetes. The agreement for this preclinical-stage agent involves an upfront ...

Clarius Group LLC lifted its holdings in shares of Sanofi (NASDAQ:SNY – Free Report) by 11.9% in the fourth quarter, ...